Mon, February 2, 2009
Sun, February 1, 2009
Sat, January 31, 2009
Fri, January 30, 2009
Thu, January 29, 2009
Wed, January 28, 2009
Tue, January 27, 2009
[ Tue, Jan 27th 2009 ]: Market Wire
SCOR: SCOR sets up Zurich Hub
Mon, January 26, 2009
Sun, January 25, 2009
Fri, January 23, 2009
Thu, January 22, 2009
Wed, January 21, 2009
Tue, January 20, 2009
Mon, January 19, 2009
Fri, January 16, 2009
Thu, January 15, 2009

Cerus Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference


  Copy link into your clipboard //health-fitness.news-articles.net/content/2009/ .. the-11th-annual-bio-ceo-investor-conference.html
  Print publication without navigation Published in Health and Fitness on , Last Modified on 2009-01-26 14:00:30 by Market Wire
          🞛 This publication is a summary or evaluation of another publication

CONCORD, Calif.--([ BUSINESS WIRE ])--Cerus Corporation (NASDAQ:CERS) announced today that company management will present at the 11th Annual BIO CEO & Investor Conference in New York City. Cerus' presentation will begin at 10:30 a.m. EST on Monday, February 9, 2009. To access the live webcast, please log on to the company's website at [ www.cerus.com ]. An archived presentation will be available on the website until February 16, 2009.

ABOUT CERUS

Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world. The Company is also pursuing regulatory approvals in the United States and other countries. The INTERCEPT red blood cell system is currently in clinical development.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.


Publication Contributing Sources